Publications
5802 Results
- Journal / Conference
- Annals of Oncology (2021) 32 (suppl_5): S867-S905 (ESMO Annual Meeting (September 16-21, 2021), accepted, E-poster, abst# 1073P)
- Year
- 2021
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1404
Quality of life (QOL) endpoints of the Phase III Intergroup S1404 adjuvant melanoma trial
- Journal / Conference
- Journal of Clinical Oncology 39, 2021 (suppl 28; abstr 144) (ASCO Quality Care Symposium (Sept 24-25, 2021), poster)
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
- Journal / Conference
- J Clin Oncol 39 (suppl 28; abstr 210) (ASCO Quality Care Symposium (Sept 24-25, 2021)) poster
- Year
- 2021
Hope-enhancement workshops in the SWOG Cancer Research Network: Feasibility of an online intervention
- Journal / Conference
- WCLC World Conference on Lung Cancer (September 8-14, 2021, virtual), oral, Abst #OA13.01
- Year
- 2021
- Research Committee(s)
- Lung
- Study Number(s)
- S1619
S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma
- Journal / Conference
- WCLC World Conference on Lung Cancer (September 8-14, 2021, virtual), mini-oral, #MA15.05
- Year
- 2021
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/A151216
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients in The U.S. ALCHEMIST Study (Alliance)
- Journal / Conference
- Clinical Cancer Research, Dec 1;27(23):6314-6322
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34580114
- PMC
- PMC8639715
- Study Number(s)
- S1513
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second Line Treatment of Metastatic Pancreatic Cancer: SWOG S1513
- Journal / Conference
- JCO Oncology Practice, Apr;18(4):e442-e451
- Year
- 2021
- Research Committee(s)
- Genitourinary and Lung
- PMID
- PMID34606328
- PMC
- PMC8360454
- Study Number(s)
- S0027, S0421, SWOG-9509
Association between Health-Related Quality of Life and Progression Free Survival in Patients with Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials
- Journal / Conference
- Journal of Clinical Oncology, Sep 23;JCO2100910. doi: 10.1200/JCO.21.00910. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID34554865
- PMC
- PMC8629339
Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35
- Journal / Conference
- Blood Advances, Nov 23;5(22):4691-4700
- Year
- 2021
- Research Committee(s)
- Leukemia
- PMID
- PMID34492682
- PMC
- PMC8759134
- Study Number(s)
- CTSU/C10701
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
- Journal / Conference
- WCLC World Conference on Lung Cancer (January 28-31, 2021, virtual), mini oral,#MA08.10
- Year
- 2021
- Research Committee(s)
- Lung
- Study Number(s)
- LUNGMAP